Cargando…

Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasu’s arteritis patients

BACKGROUND: To investigate the association between blood biomarkers and disease activity of Takayasu’s arteritis (TAK) in a follow-up cohort. METHODS: Disease activity was assessed by clinical manifestations and repeated vascular Doppler examinations. The association between erythrocyte sedimentatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jing, Wang, Yahong, Wang, Yanhong, Wang, Ying, Yang, Yunjiao, Zhao, Jiuliang, Li, Mengtao, Tian, Xinping, Zeng, Xiaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726865/
https://www.ncbi.nlm.nih.gov/pubmed/33303010
http://dx.doi.org/10.1186/s13075-020-02365-y
_version_ 1783620967602323456
author Li, Jing
Wang, Yahong
Wang, Yanhong
Wang, Ying
Yang, Yunjiao
Zhao, Jiuliang
Li, Mengtao
Tian, Xinping
Zeng, Xiaofeng
author_facet Li, Jing
Wang, Yahong
Wang, Yanhong
Wang, Ying
Yang, Yunjiao
Zhao, Jiuliang
Li, Mengtao
Tian, Xinping
Zeng, Xiaofeng
author_sort Li, Jing
collection PubMed
description BACKGROUND: To investigate the association between blood biomarkers and disease activity of Takayasu’s arteritis (TAK) in a follow-up cohort. METHODS: Disease activity was assessed by clinical manifestations and repeated vascular Doppler examinations. The association between erythrocyte sedimentation rate (ESR), serum levels of high-sensitive C-reactive protein (hsCRP), interleukin-6(IL-6), and tumor necrosis factor-α (TNFα) and disease activity were analyzed by logistic regression and survival analysis. Kaplan-Meier method was used to estimate the cumulative remission rate curve, log-rank tests for group comparison, and Cox regression for estimating hazard ratios of these parameters for disease activity. RESULTS: 428 patients were included. 188 patients were in active disease, and 240 patients were in inactive disease at baseline. Elevation of ESR, hsCRP, and IL-6 were associated with active disease at baseline and during follow-up. Cox regression and Kaplan-Meier analysis showed that lower possibility and longer time to remission were associated with elevated ESR (hazard ratio [HR] = 0.32, 80 vs 33 weeks, p < 0.001), hsCRP (HR = 0.45, 70 vs 31 weeks, p < 0.001), and IL-6 (HR = 0.54, 66 vs 34 weeks, p < 0.01) in patients with active disease at baseline, while higher risk and shorter time for relapse were associated with elevated ESR (HR = 2.1, 59 vs 111 weeks, p < 0.001), hsCRP (HR = 2.1, 79 vs 113 weeks, p < 0.001), IL-6 (HR = 2.5, 64 vs 117 weeks, p < 0.001), and TNFα (HR = 2.7, 65 vs 114 weeks, p < 0.001) in patients with inactive disease at baseline. CONCLUSIONS: Elevated ESR, CRP, and IL-6 are associated with active disease, lower possibility, and longer time to achieve disease remission. Elevation of any among ESR, CRP, IL-6, and TNFα is associated with high risk and short time for relapse during follow-up. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-020-02365-y.
format Online
Article
Text
id pubmed-7726865
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77268652020-12-10 Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasu’s arteritis patients Li, Jing Wang, Yahong Wang, Yanhong Wang, Ying Yang, Yunjiao Zhao, Jiuliang Li, Mengtao Tian, Xinping Zeng, Xiaofeng Arthritis Res Ther Research Article BACKGROUND: To investigate the association between blood biomarkers and disease activity of Takayasu’s arteritis (TAK) in a follow-up cohort. METHODS: Disease activity was assessed by clinical manifestations and repeated vascular Doppler examinations. The association between erythrocyte sedimentation rate (ESR), serum levels of high-sensitive C-reactive protein (hsCRP), interleukin-6(IL-6), and tumor necrosis factor-α (TNFα) and disease activity were analyzed by logistic regression and survival analysis. Kaplan-Meier method was used to estimate the cumulative remission rate curve, log-rank tests for group comparison, and Cox regression for estimating hazard ratios of these parameters for disease activity. RESULTS: 428 patients were included. 188 patients were in active disease, and 240 patients were in inactive disease at baseline. Elevation of ESR, hsCRP, and IL-6 were associated with active disease at baseline and during follow-up. Cox regression and Kaplan-Meier analysis showed that lower possibility and longer time to remission were associated with elevated ESR (hazard ratio [HR] = 0.32, 80 vs 33 weeks, p < 0.001), hsCRP (HR = 0.45, 70 vs 31 weeks, p < 0.001), and IL-6 (HR = 0.54, 66 vs 34 weeks, p < 0.01) in patients with active disease at baseline, while higher risk and shorter time for relapse were associated with elevated ESR (HR = 2.1, 59 vs 111 weeks, p < 0.001), hsCRP (HR = 2.1, 79 vs 113 weeks, p < 0.001), IL-6 (HR = 2.5, 64 vs 117 weeks, p < 0.001), and TNFα (HR = 2.7, 65 vs 114 weeks, p < 0.001) in patients with inactive disease at baseline. CONCLUSIONS: Elevated ESR, CRP, and IL-6 are associated with active disease, lower possibility, and longer time to achieve disease remission. Elevation of any among ESR, CRP, IL-6, and TNFα is associated with high risk and short time for relapse during follow-up. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-020-02365-y. BioMed Central 2020-12-10 2020 /pmc/articles/PMC7726865/ /pubmed/33303010 http://dx.doi.org/10.1186/s13075-020-02365-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Li, Jing
Wang, Yahong
Wang, Yanhong
Wang, Ying
Yang, Yunjiao
Zhao, Jiuliang
Li, Mengtao
Tian, Xinping
Zeng, Xiaofeng
Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasu’s arteritis patients
title Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasu’s arteritis patients
title_full Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasu’s arteritis patients
title_fullStr Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasu’s arteritis patients
title_full_unstemmed Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasu’s arteritis patients
title_short Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasu’s arteritis patients
title_sort association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in takayasu’s arteritis patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726865/
https://www.ncbi.nlm.nih.gov/pubmed/33303010
http://dx.doi.org/10.1186/s13075-020-02365-y
work_keys_str_mv AT lijing associationbetweenacutephasereactantsinterleukin6tumornecrosisfactoraanddiseaseactivityintakayasusarteritispatients
AT wangyahong associationbetweenacutephasereactantsinterleukin6tumornecrosisfactoraanddiseaseactivityintakayasusarteritispatients
AT wangyanhong associationbetweenacutephasereactantsinterleukin6tumornecrosisfactoraanddiseaseactivityintakayasusarteritispatients
AT wangying associationbetweenacutephasereactantsinterleukin6tumornecrosisfactoraanddiseaseactivityintakayasusarteritispatients
AT yangyunjiao associationbetweenacutephasereactantsinterleukin6tumornecrosisfactoraanddiseaseactivityintakayasusarteritispatients
AT zhaojiuliang associationbetweenacutephasereactantsinterleukin6tumornecrosisfactoraanddiseaseactivityintakayasusarteritispatients
AT limengtao associationbetweenacutephasereactantsinterleukin6tumornecrosisfactoraanddiseaseactivityintakayasusarteritispatients
AT tianxinping associationbetweenacutephasereactantsinterleukin6tumornecrosisfactoraanddiseaseactivityintakayasusarteritispatients
AT zengxiaofeng associationbetweenacutephasereactantsinterleukin6tumornecrosisfactoraanddiseaseactivityintakayasusarteritispatients